• Japanese
  • Korean
  • Chinese
Cover Image

Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019

Abstract

Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market. The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Hepatitis A Preventive Vaccines market. Its scope includes -

  • Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hepatitis A Preventive Vaccines market revenues data from 2006 to 2011, forecast for eight years to 2019.
  • Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
  • Analysis of the current and future competition in the seven key countries Hepatitis A Preventive Vaccines market.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hepatitis A Preventive Vaccines market.
  • Analysis of key recent licensing and partnership agreements in Hepatitis A Preventive Vaccines market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global Hepatitis A Preventive Vaccines market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hepatitis A Preventive Vaccines market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What's the next big thing in the global Hepatitis A Preventive Vaccines market landscape? - Identify, understand and capitalize.

TOC

1 Table of Contents

1 Table of Contents 3

  • 1.1 List of Tables 5
  • 1.2 List of Figures 6

2 Hepatitis A Introduction 7

  • 2.1 Disease Overview 7
  • 2.2 Epidemiology 8
    • 2.2.1 Historical Vaccination Coverage (2006-2011) 9
    • 2.2.2 Forecast Vaccination Coverage (2011-2019) 9
  • 2.3 Prognosis 10
  • 2.4 Etiology 10
  • 2.5 Pathophysiology 12
  • 2.6 Signs and Symptoms 13
  • 2.7 Diagnosis 14
  • 2.8 Treatment and Management Options 16
  • 2.9 Referral Pathway 18
  • 2.10 GlobalData Pipeline Report Guidance 20

3 Hepatitis A Preventive Vaccines - Market Characterization 21

  • 3.1 Global Hepatitis A Preventive Vaccines Market Size (2006-2011) 21
  • 3.2 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Global 22
  • 3.3 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The US 23
  • 3.4 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The US 24
  • 3.5 Hepatitis A Preventive Vaccines Market Size (2006-2011) - France 25
  • 3.6 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - France 26
  • 3.7 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Germany 27
  • 3.8 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Germany 28
  • 3.9 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Italy 29
  • 3.10 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Italy 30
  • 3.11 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Spain 31
  • 3.12 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Spain 32
  • 3.13 Hepatitis A Preventive Vaccines Market Size (2006-2011) - The UK 33
  • 3.14 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - The UK 34
  • 3.15 Hepatitis A Preventive Vaccines Market Size (2006-2011) - Japan 35
  • 3.16 Hepatitis A Preventive Vaccines Market Forecast (2011-2019) - Japan 36
  • 3.17 Drivers and Barriers for the Hepatitis A Preventive Vaccines Market 37
    • 3.17.1 Drivers for the Hepatitis A Preventive Vaccines Market 37
    • 3.17.2 Barriers for the Hepatitis A Preventive Vaccines Market 37
  • 3.18 Opportunity and Unmet Need Analysis 38
  • 3.19 Key Takeaway 39

4 Hepatitis A Preventive Vaccines - Competitive Assessment 40

  • 4.1 Overview 40
  • 4.2 Strategic Competitor Assessment 40
  • 4.3 Product Profiles for the Major Marketed class of Products in the Hepatitis A Market 41
    • 4.3.1 Havrix 41
    • 4.3.2 Vaqta 42
    • 4.3.3 Twinrix 44
    • 4.3.4 Ambirix 45
    • 4.3.5 Avaxim 46
    • 4.3.6 Epaxal 46
  • 4.4 Key Takeaway 47

5 Hepatitis A Preventive Vaccines - Clinical Trials Mapping 48

  • 5.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 48
  • 5.2 Clinical Trials by Phase 49
  • 5.3 Clinical Trials by Trial Status 50
  • 5.4 Prominent Sponsors 51
  • 5.5 Clinical Trials by Overall Sponsors 52
  • 5.6 Top Companies Participating in Hepatitis A Preventive Vaccines Clinical Trials 53

6 Hepatitis A Preventive Vaccines - Strategic Assessment 54

  • 6.1 Key Events Impacting the Future Market 54
  • 6.2 Hepatitis A Preventive Vaccines: Implications for Future Market Competition 55

7 Hepatitis A Preventive Vaccines - Future Players 56

  • 7.1 Introduction 56
  • 7.2 Company Profiles 56
    • 7.2.1 GlaxoSmithKline 56
    • 7.2.2 Merck & Co 56
    • 7.2.3 Crucell 57

8 KOL Insights 58

9 Hepatitis A Preventive Vaccines - Appendix 59

  • 9.1 Market Definitions 59
  • 9.2 Abbreviations 59
  • 9.3 Bibliography 60
  • 9.4 Methodology 61
    • 9.4.1 Coverage 61
    • 9.4.2 Secondary Research 61
    • 9.4.3 Forecasting 62
    • 9.4.4 Primary Research 64
    • 9.4.5 Expert Panel Validation 65
  • 9.5 Contact Us 65
  • 9.6 Disclaimer 65

List of Tables

1.1 List of Tables

  • Table 1: Comparison between Hepatitis A, B and C 7
  • Table 2: HAV Endemicity by Region 8
  • Table 3: Vaccination Coverage (In Percentage) 9
  • Table 4: Vaccination Coverage (In Percentage) 9
  • Table 5: History and Physical Examination 14
  • Table 6: Laboratory and Other Studies for Hepatitis A 15
  • Table 7: Differential Diagnosis of hepatitis A 15
  • Table 8: Havrix Dosage and Schedule for Vaccination 16
  • Table 9: Vaqta Dosage and Schedule for Vaccination 16
  • Table 10: Twinrix Dosage and Schedule for Vaccination 16
  • Table 11: UK Guidelines For Hepatitis A Vaccination 17
  • Table 12: Japanese Hepatitis A Vaccine, Dosage and Schedule 17
  • Table 13: Hepatitis A Preventive Vaccines Market, Global, Revenue ($m), 2006-2011 21
  • Table 14: Hepatitis A Preventive Vaccines Market, Global, Forecast ($m), 2011-2019 22

Table 15 Hepatitis A Preventive Vaccines Market, The US, Revenue ($m), 2006-2011 23

  • Table 16: Hepatitis A Preventive Vaccines, The US, Forecast ($m), 2011-2019 24
  • Table 17: Hepatitis A Preventive Vaccines Market, France, Revenue ($m), 2006-2011 25
  • Table 18: Hepatitis A Preventive Vaccines, France, Forecast ($m), 2011-2019 26
  • Table 19: Hepatitis A Preventive Vaccines Market, Germany, Revenue ($m), 2006-2011 27
  • Table 20: Hepatitis A Preventive Vaccines Market, Germany, Forecast ($m), 2011-2019 28
  • Table 21: Hepatitis A Preventive Vaccines Market, Italy, Revenue ($m), 2006-2011 29
  • Table 22: Hepatitis A Preventive Vaccines Market, Italy, Forecast ($m), 2011-2019 30
  • Table 23: Hepatitis A Preventive Vaccines Market, Spain, Revenue ($m), 2006-2011 31
  • Table 24: Hepatitis A Preventive Vaccines, Spain, Forecast ($m), 2011-2019 32
  • Table 25: Hepatitis A Preventive Vaccines Market, The UK, Revenue ($m), 2006-2011 33
  • Table 26: Hepatitis A Preventive Vaccines Market, The UK, Forecast ($m), 2011-2019 34
  • Table 27: Hepatitis A Market, Japan, Revenue ($m), 2006-2011 35
  • Table 28: Hepatitis A Preventive Vaccines Market, Japan, Forecast ($m), 2011-2019 36
  • Table 29: Hepatitis A Preventive Vaccines - Clinical Trials by Region/ Country, 2012 48
  • Table 30: Hepatitis A Preventive Vaccines - Clinical Trials by Phase, 2012 49
  • Table 31: Hepatitis A Preventive Vaccines - Clinical Trials by Status, 2012 50
  • Table 32: Hepatitis A Preventive Vaccines - Prominent Sponsors, 2012 51
  • Table 33: Hepatitis A Preventive Vaccines - Overall Sponsors, 2012 52
  • Table 34: Hepatitis A Preventive Vaccines - Top Companies Participating in Clinical Trials, 2012 53

List of Figures

1.2 List of Figures

  • Figure 1: Prevalence of Hepatitis A Virus by Region 8
  • Figure 2: Incidence of Hepatitis A, 1980-2009 10
  • Figure 3: Pathophysiology of Hepatitis A 12

Figure 4 : Symptoms of Hepatitis A infection 13

  • Figure 5: Referral Pathway for HAV Vaccination 18
  • Figure 6: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 19
  • Figure 7: Hepatitis A Preventive Vaccines Market, Global, Revenue ($m), 2006-2011 21
  • Figure 8: Hepatitis A Preventive Vaccines Market, Global, Forecast ($m), 2011-2019 22

Figure 9 Hepatitis A Preventive Vaccines, The US, Revenue ($m), 2006-2011 23

  • Figure 10: Hepatitis A Preventive Vaccines, The US, Forecast ($m), 2011-2019 24
  • Figure 11: Hepatitis A Preventive Vaccines Market, France, Revenue ($m), 2006-2011 25
  • Figure 12: Hepatitis A Preventive Vaccines, France, Forecast ($m), 2011-2019 26
  • Figure 13: Hepatitis A Preventive Vaccines Market, Germany, Revenue ($m), 2006-2011 27
  • Figure 14: Hepatitis A Preventive Vaccines Market, Germany, Forecast ($m), 2011-2019 28
  • Figure 15: Hepatitis A Preventive Vaccines Market, Italy, Revenue ($m), 2006-2011 29
  • Figure 16: Hepatitis A Preventive Vaccines Market, Italy, Forecast ($m), 2011-2019 30
  • Figure 17: Hepatitis A Preventive Vaccines Market, Spain, Revenue ($m), 2006-2011 31
  • Figure 18: Hepatitis A Preventive Vaccines Market, Spain, Forecast ($m), 2011-2019 32
  • Figure 19: Hepatitis A Preventive Vaccines Market, The UK, Revenue ($m), 2006-2011 33

Figure 20 : Hepatitis A Preventive Vaccines Market, The UK, Forecast ($m), 2011-2019 34

Figure 21 : Hepatitis A Preventive Vaccines Market, Japan, Revenue ($m), 2006-2011 35

  • Figure 22: Hepatitis A Preventive Vaccines Market, Japan, Forecast ($m), 2011-2019 36
  • Figure 23: Opportunity and Unmet Need in the Hepatitis A Preventive Vaccines Market, 2012 38
  • Figure 24: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 39
  • Figure 25: Hepatitis A Preventive Vaccines - Strategic Competitor Assessment, 2012 41
  • Figure 26: KOL Insights, Hepatitis A Preventive Vaccines in the US, Europe and Japan 47
  • Figure 27: Hepatitis A Preventive Vaccines - Clinical Trials by Country, 2012 48
  • Figure 28: Hepatitis A Preventive Vaccines - Clinical Trials by Phase, 2012 49
  • Figure 29: Hepatitis A Preventive Vaccines - Clinical Trials by Status, 2012 50
  • Figure 30: Hepatitis A Preventive Vaccines - Prominent Sponsors, 2012 51
  • Figure 31: Hepatitis A Preventive Vaccines - Overall Sponsors, 2012 52
  • Figure 32: Hepatitis A Preventive Vaccines - Top Companies Participating in Clinical Trials, 2012 53
  • Figure 33: Hepatitis A Preventive Vaccines Market - Drivers and Restraints 2012 54
  • Figure 34: Implications for Future Market Competition in Hepatitis A Preventive Vaccines Market, 2012 55
  • Figure 35: Hepatitis A Preventive Vaccines - Marketed Products by Company, 2012 56
  • Figure 36: KOL Insights, Hepatitis A Preventive Vaccines, Major Market 58
  • Figure 37: GlobalData Market Size Estimation 62

Figure 38 : GlobalData Market Forecasting Model 64

Show More
Pricing